|
|
Volumn 2, Issue 4, 1998, Pages 1-45
|
|
A cost-utility analysis of interferon beta for multiple sclerosis
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
BACLOFEN;
BROMOCRIPTINE;
CEFALEXIN;
COCODAMOL;
INTERFERON BETA SERINE;
OXYBUTYNIN;
PREDNISOLONE;
TRIMETHOPRIM;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
COST UTILITY ANALYSIS;
DIAGNOSTIC TEST;
HEALTH CARE COST;
HUMAN;
MULTIPLE SCLEROSIS;
PRESCRIPTION;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
RELAPSE;
REMISSION;
REVIEW;
|
|
EID: 0031812974
PISSN: 13665278
EISSN: None
Source Type: Journal
DOI: 10.3310/hta2040 Document Type: Review |
|
Times cited : (73)
|
|
References (76)
|